Dr. Reddy's enters into exclusive sales and distribution agreement with Novartis India

12 Feb 2022 Evaluate

Dr. Reddy's Laboratories has entered into an exclusive sales and distribution agreement with Novartis India (NIL) for the Voveran range, the Calcium range and Methergine in India.

Under the arrangement, Dr. Reddy’s will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium range and Methergine in India. The company will use its strengths in promotion and distribution to considerably expand its engagement with healthcare professionals with the aim of enabling access to patients in need.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1195.80 9.35 (0.79%)
16-Jan-2026 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1682.95
Dr. Reddys Lab 1195.80
Cipla 1400.60
Zydus Lifesciences 885.40
Lupin 2208.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×